Your search for "values" return 29 results.
2016 was a year of sustained organic growth and major acquisitions. Consolidated sales reached €912m.
Ceva acquires portfolio of Merial swine and cattle vaccines and nonsteroidal anti-inflammatories from Boehringer Ingelheim >
These products are expected to create tremendous value for the global organization.
Phase 2 Study calls for fighting both the mosquito and the heartworm
Julie Schwalbe has joined Ceva Animal Health’s swine business unit as strategic account manager.
The meeting sought to understand the continuing threat posed by AI and the value of vaccination in changing times.
Ceva Biomune has broken ground on a new facility to meet demand for its vaccine products.
Ceva Biomune has again expanded facilities to meet demand for its vaccine products.
Ceva announced its commitment to Fear Free,™ an innovative initiative developed by “America’s Veterinarian” Dr. Marty Becker to “take the pet out of petrified and get pets back into practices.”
Ceva receives US patent for innovative delivery system of treating poultry hatchlings through gel application >
Poultry producers now have access to a new method for administering vaccines, probiotics and nutritional supplements in the hatchery through a soft edible gel.
Travis Cigainero, DVM has joined Ceva Animal Health as Manager of Broiler Technical Services